KTRA

Kintara Therapeutics (KTRA)

Kintara Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KTRA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/15	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2025/02/08	07:17	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2025/01/07	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2025/01/07	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/12/24	07:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/12/12	23:07	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/12/12	23:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/11/25	22:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/11/16	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/11/15	07:20	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/11/15	07:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/11/15	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/26	05:30	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/26	05:28	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/26	05:26	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/26	05:23	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/26	05:20	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	10:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:50	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:38	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:13	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	09:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/23	08:56	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/21	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/17	01:54	PR Newswire (US)	Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/17	00:58	PR Newswire (US)	Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/10/16	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KTRA	Kintara Therapeutics Inc